James Shin
Stock Analyst at Deutsche Bank
(2.66)
# 1,935
Out of 5,165 analysts
24
Total ratings
54.55%
Success rate
19.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,200 → $1,285 | $930.35 | +38.12% | 6 | Feb 9, 2026 | |
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $115.87 | -4.20% | 3 | Nov 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $9.83 | +1.73% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $144.40 | -16.90% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $361.13 | -15.54% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $94.22 | -36.32% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $59.71 | -24.64% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $18.55 | +223.45% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $219.76 | -31.74% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $759.05 | +5.39% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.51 | +562.25% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $22.94 | +423.22% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Feb 9, 2026
Maintains: Buy
Price Target: $1,200 → $1,285
Current: $930.35
Upside: +38.12%
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $115.87
Upside: -4.20%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $9.83
Upside: +1.73%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $144.40
Upside: -16.90%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $361.13
Upside: -15.54%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $94.22
Upside: -36.32%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $59.71
Upside: -24.64%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $18.55
Upside: +223.45%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $219.76
Upside: -31.74%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $759.05
Upside: +5.39%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Nov 9, 2023
Initiates: Buy
Price Target: $120
Current: $22.94
Upside: +423.22%